NCBI PubMed Central
open access
FDA Approves Reduced Drinking Endpoints for Alcohol Trials: A New Road for Alcohol Treatment?
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
Related documents
- Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy#1088620
- Pharmacological interventions for alcohol use disorder: novel insights from recent clinical trials.#148417
- Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics#1161925
- Systematic Implementation of Patient-centered Care for Alcohol Use Trial: Beyond Referral to Treatment#807172
- Examining the Impact of Trial Length on Detecting Medication Effects for Alcohol Use Disorder: A Meta-Regression Study.#275351
Record · ID 251193 · SHA-256 18826624a7c8f1fe
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive